Harvey PD - Search Results

1

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA. Keefe RS, et al. Among authors: harvey pd. Neuropsychopharmacology. 2006 Sep;31(9):2033-46. doi: 10.1038/sj.npp.1301072. Epub 2006 Apr 19. Neuropsychopharmacology. 2006. PMID: 16641947 Clinical Trial.

2

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study.

Harvey PD, Green MF, McGurk SR, Meltzer HY. Harvey PD, et al. Psychopharmacology (Berl). 2003 Sep;169(3-4):404-11. doi: 10.1007/s00213-002-1342-5. Epub 2003 Feb 18. Psychopharmacology (Berl). 2003. PMID: 12590356 Clinical Trial.

3

Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.

Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. Keefe RS, et al. Among authors: harvey pd. Schizophr Bull. 2003;29(1):45-55. doi: 10.1093/oxfordjournals.schbul.a006990. Schizophr Bull. 2003. PMID: 12908660

4

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia.

Harvey PD, Meltzer H, Simpson GM, Potkin SG, Loebel A, Siu C, Romano SJ. Harvey PD, et al. Schizophr Res. 2004 Feb 1;66(2-3):101-13. doi: 10.1016/j.schres.2003.07.009. Schizophr Res. 2004. PMID: 15061242 Clinical Trial.

5

Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.

Harvey PD, Green MF, Keefe RS, Velligan DI. Harvey PD, et al. J Clin Psychiatry. 2004 Mar;65(3):361-72. J Clin Psychiatry. 2004. PMID: 15096076 Review.

6

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. Keefe RS, et al. Among authors: harvey pd. Schizophr Res. 2004 Jun 1;68(2-3):283-97. doi: 10.1016/j.schres.2003.09.011. Schizophr Res. 2004. PMID: 15099610

7

Cognitive functioning predicts outpatient service utilization in schizophrenia.

McGurk SR, Mueser KT, Walling D, Harvey PD, Meltzer HY. McGurk SR, et al. Among authors: harvey pd. Ment Health Serv Res. 2004 Sep;6(3):185-8. doi: 10.1023/b:mhsr.0000036491.58918.71. Ment Health Serv Res. 2004. PMID: 15473104

8

Stability of cognitive performance in older patients with schizophrenia: an 8-week test-retest study.

Harvey PD, Palmer BW, Heaton RK, Mohamed S, Kennedy J, Brickman A. Harvey PD, et al. Am J Psychiatry. 2005 Jan;162(1):110-7. doi: 10.1176/appi.ajp.162.1.110. Am J Psychiatry. 2005. PMID: 15625208

9

From clinical research to clinical practice: a 4-year review of ziprasidone.

Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, Kilts CD, Daniel DG. Nemeroff CB, et al. Among authors: harvey pd. CNS Spectr. 2005 Nov;10(11 Suppl 17):1-20. doi: 10.1017/s1092852900019842. CNS Spectr. 2005. PMID: 16381088

10

The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome.

Keefe RS, Poe M, Walker TM, Harvey PD. Keefe RS, et al. Among authors: harvey pd. J Clin Exp Neuropsychol. 2006 Feb;28(2):260-9. doi: 10.1080/13803390500360539. J Clin Exp Neuropsychol. 2006. PMID: 16484097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

835 results

Search Page

Filters